SUMMARY
INTRODUCTION
The cranial vault undergoes intramembranous bone formation and provides mechanical support and protection for the brain. Important elements of the calvarial structure are the sutures that narrow during appositional bone growth and remain as an active site of bone formation during calvarial development. In 2007, Lana-Elola et al. showed that during calvarial development, mesenchymal cells of the sutures differentiate to form calvarial bone and their differential fate depends on positioning, with cells occupying the midline of the suture mesenchyme less prone to differentiation. In 2014, Ouyang et al. published a thorough observation about PRX1-expressing cells of the postnatal calvaria, showing that these cells have qualities of skeletal stem cells (SSCs), reside in the calvarial sutures, and are distinct from postnatal cells of the sutures expressing Collagen 1 (COL1). Zhao et al. (2015) and, more recently, Maruyama et al. (2016) showed that various populations of SSCs reside in postnatal calvarial sutures, supporting the logic that the stem cell niche of the calvaria is contained in the suture mesenchyme. Additional research about SSCs of the calvaria and their niche is required to devise therapeutic strategies which, by targeting a specific population of SSCs, can promote calvarial bone regeneration or perturb the development of craniofacial malformations, such as craniosynostosis.
The pair-related homeobox gene Prx1 (also known as Prrx1) is a transcription factor that is highly expressed during limb bud formation and craniofacial development (Martin and Olson, 2000) . PRX1-expressing cells and their postnatal progeny also have a central role in bone homeostasis and fracture repair since inactivation of RANKL (receptor activator of nuclear factor kB ligand) expression in these cells causes osteopetrosis (Xiong et al., 2011) and inactivation of BMP2 (bone morphogenetic protein 2) expression generates a low-bone-mass phenotype, with bones prone to factures and unable to repair (Tsuji et al., 2006) . In culture, PRX1-expressing cells isolated from the periosteum of postnatal long bones (Kawanami et al., 2009) or postnatal calvaria (Ouyang et al., 2014) can differentiate into chondroblasts and osteoblasts upon induction. Additional studies show that PRX1 averts differentiation of cells into committed osteoblasts (Lu et al., 2011) or adipocytes (Du et al., 2013) . Together, the evidence suggests that expression of Prx1 is a unique marker to identify and characterize SSCs of the calvarial bones. We therefore hypothesize that postnatal cells expressing PRX1 (pnPRX1 + ) of the calvaria represent an SSC population that resides exclusively in the sutures and is required for calvarial bone regeneration. Using intravital microscopy (IVM) (Lo Celso et al., 2009) , we performed lineage-tracing analyses and lineage-ablation analyses to show that pnPRX1 + cells reside exclusively in the sutures, are required for regeneration of calvarial bone defects, and are dispensable for postnatal calvarial development.
RESULTS

pnPRX1 + Cells of the Calvaria Reside in Calvarial
Sutures and Decrease in Number with Age Prx1-creER-EGFP transgenic mice expressing GFP (EGFP) under the control of the Prx1 promoter (Kawanami et al., 2009) were imaged by IVM (Lo Celso et al., 2009 ) to investigate the presence of pnPRX1 + cells in calvarial bone and calvarial sutures. We found pnPRX1 + cells located exclusively in the posterior frontal, coronal, sagittal, and lambdoid sutures ( Figure 1A ). pnPRX1 + cells were not found in other craniofacial sutures ( Figure 1B ), the calvarial periosteum, or the dura mater ( Figure S1 ). In addition, pnPRX1 + cells
were not present in the calvarial bone marrow of mature mice (Figure 1Ca ), where postnatal osteoblasts expressing COL1 (Kern et al., 2001 ) (pnCOL1 + cells) are commonly found (Figure 1Cb ). Within the coronal suture, pnPRX1 + cells were quantified at 8, 16, 24, and 32 weeks of age and data analysis showed a 75% reduction of cells between 8 and 32-week-old animals ( Figure 1D ). We also quantified the total cellularity of the suture to determine whether there was a reduction in cell density and found no difference in total cell numbers between 8-and 32-week-old animals ( Figure S2 ). These data confirm that pnPRX1 + cells distinctively populate the calvarial sutures and that their number decreases with age.
pnPRX1 + Cells of the Calvarial Sutures Are Distinct from Preosteoblasts and Osteoblasts of the Calvaria
Given the localization of pnPRX1 + cells, we hypothesized that they are distinct from postnatal preosteoblasts expressing Osterix (pnOSX + cells) (Nakashima et al., 2002) .
To test this hypothesis, we imaged Prx1-creER-EGFP mice crossed with Osterix_mCherry reporter mice (Strecker et al., 2013) . Our data reveal that pnPRX1 + cells do not co-express OSX in the calvarial sutures ( Figure 1Ea ). Consistent with Ouyang et al. (2014) , pnPRX1 + cells are also distinct from postnatal osteoblasts expressing COL1 (pnCOL1 + cells [Kalajzic et al., 2002; Kern et al., 2001] ). In fact, pnCOL1 + cells were detected by the osteogenic fronts of the sutures but were never found within the suture space mesenchyme (Figure 1Eb ). We conclude that pnPRX1 + cells of the calvarial sutures are distinct from preosteoblasts and osteoblasts of the calvaria.
PRX1-Expressing Cells and Their Progeny Are
Responsible for the Development of the Calvarial Sutures and Calvarial Bones, and for Regeneration of the Calvarial Bones We performed lineage-tracing analysis to determine whether PRX1-expressing cells and their progeny are responsible for the development of calvarial sutures. To this end, Prx1-Cre mice (Logan et al., 2002) were crossed with fl/fl tdTOMATO reporter mice (tdTOMATO mice) (Madisen et al., 2010) . Coronal sutures were imaged by IVM and tdTOMATO was detected in the suture space, the surrounding periosteum, osteogenic fronts of the suture, and mature bone (as osteocytes) of both neural crest-derived (frontal) (Jiang et al., 2002) and mesodermderived (parietal) (Yen et al., 2010) bones of Prx1-cre +/À ;tdTOMATO +/À mice ( Figure 2A ). To confirm the results, we crossed the Prx1-Cre mice with transgenic mice able to express diphtheria toxin A (DTA) upon CRE recombination of a loxP-flanked STOP cassette (Voehringer et al., 2008) . The Prx1-cre +/À ;DTA +/À mice at birth (postnatal day 0 [P0]) displayed incomplete development of the frontal bone and lack of development of the parietal, interparietal, and occipital bones ( Figure 2Ba ). The posterior frontal, coronal, sagittal, and lambdoid sutures were also absent. Gross anatomical inspection revealed impaired limb development in these mice ( Figure 2Bb ) and validated our experimental approach, since PRX1 is also expressed in developing limbs (Logan et al., 2002) . These lineage-tracing and lineage-ablation analyses indicate that embryonic cells expressing PRX1, their postnatal progeny, and, possibly, postnatal cells expressing PRX1 cells are responsible for development of neural crest-derived (i.e., frontal bone) (Jiang et al., 2002 ) and mesoderm-derived (i.e., parietal bone) (Yen et al., 2010) calvarial bones. Thus, expression of PRX1 identifies a population of cells of mixed neural crest and mesoderm origins.
To test whether PRX1-expressing cells and their progeny also regenerate calvarial bones, we evaluated their contribution to regeneration of a subcritical defect (Cowan et al., 2004) in the frontal and parietal bones of 8-weekold Prx1-cre +/À ;tdTOMATO +/À animals ( Figure 2C ). IVM
analysis of the regenerated bones shows cells expressing tdTOMATO in the defects 5 days post surgery, increased progeny 10 days post surgery, and in bone formed 30 days post surgery. We concluded that progeny of embryonic cells expressing PRX1 and possibly pnPRX1 + cells contribute to the regeneration of neural crest-derived (frontal) (Jiang et al., 2002) and mesoderm-derived (parietal) (Yen et al., 2010) calvarial bones. Thus, postnatal expression of PRX1 may identify a population of cells that contribute to or are directly responsible for calvarial bone regeneration. (C) Lineage-tracing analysis of the PRX1-expressing cells of the neural crest-derived frontal (F) and mesoderm-derived parietal (P) bones during bone regeneration in 8-week-old PRX1-cre +/À ;tdTOMATO +/À mice. Images were acquired at the time of the defect creation (t0), 5 days later (t5), 10 days later (t10), and 30 days later (t30) to show Prx1 progeny migrating into the defect (white dotted lines) and forming new bones as osteocytes (white arrows) (n = 3 mice). Scale bars, 50 mm. mice into a critical-size calvarial bone defect (2 mm in diameter) (Cowan et al., 2004) of wild-type mice (C57BL/6) (heterotopic transplantation, Figure 3A ). Wildtype hosts were then injected with tamoxifen to induce tdTOMATO expression in the progeny of the transplanted pnPRX1 + cells within the newly regenerated bone. Results
show that transplanted suture tissue (heterotopic site) is able to regenerate bone rather than suture-like structures and that pnPRX1 + cells of the sutures give rise to the majority of the cells incorporated into the newly formed bone. ;tdTOMATO +/À mice into criticalsize calvarial bone defects created in wildtype mice (C57BL/6). Bone defects are identified by the red dashed lines (n = 2-3 mice/group). Scale bars, 100 mm. (B) Micro-computed tomography and histological sections of calvarial bones dissected 28 days after subcritical calvarial defect surgery (0.5 mm in diameter) in the presence (left) (mice treated with tamoxifen but not carrying the DTA transgene) and absence (right) (mice treated with tamoxifen and carrying the DTA transgene) of pnPRX1 + cells. Dashed lines demarcate the calvarial subcritical bone defect (n = 6 mice). Histology scale bars, 100 mm. (C) Interval Lineage-tracing analysis of pnPRX1 + cells in defect healing (100 mm in diameter, white dotted lines) using 8-weekold PRX1-creER +/À ;tdTOMATO +/À mice. Images acquired at the time of defect creation (t0), five days later (t5), 10 days later (t10) (n = 6 mice), and 60 days later (t60) (n = 2 mice). Scale bars, 50 mm. To expand on the data, we used Prx1-CreEr-EGFP To confirm that only the pnPRX1 + cells of the calvarial sutures contribute to the regeneration of calvarial defects and therefore that the calvarial suture is their exclusive niche, we isolated the contribution of other potential sources of pnPRX1 + cells. First, we created a subcritical calvarial defect in the parietal bone of the calvaria while concomitantly performing suturectomy (without affecting the underlying dura). Previously we showed that parietal bone defects are unable to heal if a suturectomy of the surrounding coronal and sagittal sutures is performed concomitantly to the creation of the defect. The results demonstrate that subcritical-size bone defects are unable to heal in absence of surrounding intact sutures ( Figure 3D ). In a second ;tdTOMATO +/À mice into wild-type mice (orthotopic transplantation, Figure 3E ). Six weeks after transplantation, host mice (wild-type) were treated with tamoxifen and a subcritical-size defect was created in the parietal bone surrounded by the transplanted sutures. IVM analysis showed that progeny of the transplanted pnPRX1 + cells (tdTOMATO + ) appear within the deepest portion of the parietal defect 7 days after surgery. Fourteen days after surgery, we saw progeny of the transplanted pnPRX1 + cells incorporated in the newly regenerated bone and in the nearby tissue. tdTOMATO-expressing cells were not seen in the contralateral parietal bone. Therefore, since a regional suturectomy averts bone regeneration and pnPRX1 (Chan et al., 2015; Houlihan et al., 2012; Pinho et al., 2013; Sacchetti et al., 2007) . pnPRX1 + cells also express low levels of genes associated with cell cycle progression, chromosome segregation, and DNA replication such as Ccne2, Mcm4, and Pcna which are characteristic of quiescent cells (Cheung and Rando, 2013) . Higher levels of Itga2, Itga3, and Itga6 genes associated with stem cell homing and anchoring to the extracellular matrix of the niches (Chen et al., 2013; Cheung and Rando, 2013) were also detected in pnPRX1 + cells. Finally, pnPRX1 + cells express high levels of Dkk1 and Sost, two inhibitors of the WNT signaling pathway (Baron and Kneissel, 2013) that are suggested to contribute to the maintenance of the undifferentiated quiescent status of the pnPRX1 + cells.
Canonical WNT signaling is significantly active during craniofacial bone formation (Mani et al., 2010) . Therefore, to test the differentiation potential of pnPRX1 + cells, we stimulated pnPRX1 + cells cultured in vitro with recombinant mouse WNT3a (rmWNT3a) for 48 hr and found an increase in the expression of osteoblast-specific markers and reduction in the expression of Sox9, a welldefined chondroblastic marker ( Figure 4C ; Figure 4D ; Table 1 ). Validation of the subperiosteal local injection was confirmed by IVM ( Figure S4 ). In the Postnatal Suture, PRX1-Expressing Cells Overlap with GLI1-Expressing Cells In adult mice, GLI1 marks the vast majority of the suture mesenchyme with the exception of few cells at the osteogenic fronts (Zhao et al., 2015) . Our model shows Axin2 Mm00443610_m1
Col1A1 Mm00801666_g1
Osx/Sp7 Mm04209856_m1
Pdgfr alpha Mm00440701_m1 ; tdTOMATO +/À suture expressing tdTOMATO after shortpulsing of tamoxifen confirms that this difference is not due to a lower recombination efficiency of the Prx1-creER-EGFP transgene ( Figure S5 ). Furthermore, in situ hybridization confirms that expression of endogenous Prx1 is recapitulated by the expression of the Prx1-creER-EGFP transgene ( Figure S6 ). We then hypothesized that pnPRX1 Figure 5B ).
Since upregulation of Axin2 is reported to be induced by agonists of WNT signaling (Baron and Kneissel, 2013) , we tested whether the expression levels of Axin2 in pnPRX1 + cells could be increased by rmWNT3a.
Data show that pnPRX1 + cells treated with rmWNT3a
in vitro increases Axin2 expression by $5-fold (Figure 5C ; Table 1 ). This WNT-specific responsiveness was confirmed by the observed inhibition of Axin2 expression upon co-treatment with recombinant DKK1 (Figure 5C ). In vivo, we found that subperiosteal delivery ; tdTOMATO +/À mice, respectively (short-pulsing with tamoxifen for 5 days). Phase-contrast images are shown to facilitate anatomical localization. M, molar teeth; I, incisor tooth (n = 2 mice). Histology scale bars, 100 mm. of rmWNT3a by the calvarial sutures induces osteodifferentiation of pnPRX1 + cells ( Figure 4D ) and overexpression of Axin2 in pnPRX1 + cells ( Figure 5D ; Figure 6A ). Only changes in the length of the femur and the tibia presented a statistically significant difference ( Figure 6A ). When we ablated pnPRX1 + cells in P7
Prx1-creER-EGFP +/À ;DTA +/À mice, we observed a similar trend ( Figure 6B ). Global ablation of pnPRX1 + cells at P28 has a significant effect on the length of the long bones, suggesting that either a significant pool of pnPRX1 + is still needed for development of postnatal long bones or that pnPRX1 + cells have a different role in endochondral bone formation and elongation. Nevertheless, in the calvaria, results differ from the effects observed upon ablation of the widely present pnGLI1 + cells, which results in skull growth arrest and craniosynostosis (Zhao et al., 2015) . We show that pnPRX1 + are necessary for subcritical calvarial bone defect regeneration ( Figure 6C ) and are dispensable for calvarial development.
Since ablation of pnPRX1 + cells has no developmental effects on craniofacial development, we also hypothesized that the distribution of the pnPRX1 + cells across craniofacial tissues is limited. Results of our investigation in tamoxifen short-pulsed 4-week-old Prx1-creER-EGFP +/À ;tdTOMATO +/À mice support our hypothesis and show that pnPRX1 + cells expressing tdTOMATO are specifically associated only with continuously regenerating tissues, such as the incisor (Zegarelli, 1944; Figure 6D, left) . Using the same short-pulsing strategy in 4-weekold Gli1-creER
;tdTOMATO +/À mice, we identified pnGLI1 + cells in the incisor and in other more metabolically stable tissues, such the molars and the mandibular bone ( Figure 6D , right), indicating that Prx1 expression is more restricted than Gli1 expression in craniofacial tissues.
DISCUSSION
In this work, we confirm that pnPRX1 + cells of the calvaria presented gene expression profiles of SSC's, are localized to the calvarial suture niche, and are required for calvarial bone regeneration. Global ablation strategies of SSCs do not allow to unequivocally conclude that individual locations (i.e., the sutures) represent their unique niches because absence of the cells from other locations may be responsible for the observed effects. We evaluated the contribution of pnPRX1 + cells of the sutures to calvarial bone regeneration in three different settings (global ablation, regional suturectomy, and orthotopic suture transplantation). This triple experimental strategy allowed us to confirm that sutures are the exclusive niches of the calvarial SSCs expressing PRX1.
Our work demonstrates that expression of PRX1 identifies a subpopulation of the pnGLI1 + cells identified by Zhao et al. (2015) . Interestingly, global ablation of pnPRX1 + cells does not result in a major developmental phenotype whereas global ablation of pnGLI1 + cells averts craniofacial growth and induces craniosynostosis. This is expected for two reasons: First, pnPRX1 + cells are discretely distributed across the suture space and their ablation should therefore generate a phenotype less significant than the one obtained by ablation of the widely distributed pnGLI1 + cells. Second, preosteoblasts and osteoblasts of the calvaria have life spans longer than 60 days (Park et al., 2012) and represent a reservoir of cells able to form bone even in absence of their progenitors (in our case pnPRX1 + cells). Thus, the effects of the ablation of SSCs should be seen in long-term studies and may influence craniofacial development only if ablation is performed early enough during development, when a significant pool of SSCs is required. Indeed, when global ablation of PRX1-expressing cells is performed during embryogenesis, we observe an incomplete calvarial bone formation. Maruyama et al. (2016) did not perform global ablation studies of pnAXIN2 + cells. However, the fact that postnatal OSTERIX-expressing cells co-express AXIN2 (Tan et al., 2014) and the fact that Osx is expressed in preosteoblasts (Nakashima et al., 2002; Strecker et al., 2013) suggests that ablation of pnAXIN2 + cells could generate a more significant development phenotype than the one observed in the pnPRX1 + cell ablation studies. Although gene knockout studies cannot be correlated to ablation studies of cells expressing the same genes, the fact that knockout of Axin2 generates premature suture closing and craniosynostosis (Yu et al., 2005) suggests that this may in fact be the case. Our studies indicate that pnPRX1 + cells express low levels of Axin2 and that these levels increase upon WNT agonist stimulation. This result may indicate that either pnPRX1 In conclusion, our studies showed that pnPRX1 + cells are responsible for calvarial bone regeneration and represent an initial step toward future investigations aiming to identify novel, effective therapies for calvarial malformations and defects.
EXPERIMENTAL PROCEDURES
Animals
Experiments were conducted in compliance with the Guide for the Care and Use of Laboratory Animals (IACUC approval IS00000535). The transgenic mouse lines studied include Prx1-cre mice, Prx1-creER-EGFP mice, Col1-EGFP mice, Osx-mCherry mice, Rosa26LoxP -STOP-loxP-tdtomato (in this study named tdTOMATO mice), and Rosa26LoxP -STOP-loxP-DTA (in this study named DTA mice). Only male mice were utilized throughout the reported in vivo studies.
Intravital Microscopy
IVM was performed as previously described (Lo Celso et al., 2009) . The excitation beam is focused into the sample plane using a 603 objective lens (numerical aperture = 1). Fluorescence emission is then collected by either confocal or two-photon detectors with proper dichroic and filter settings corresponding to fluorophores of interest. EGFP signals are detected with a 525/38-nm bandpass filter using either two-photon or confocal acquisition excited by a 491-nm laser (Cobolt Calypso). Prx1 progeny expressing tdTOMATO are excited by a Ti:Sapphire laser at 750 nm and detected with a 625/50-nm bandpass filter. Confocal acquisition of Osx-mCherry cells are excited by a 561-nm laser (Cobolt Jive) and detected using a 695/55-nm bandpass filter. For visualization of bones, second harmonic generation (SHG) of collagen is excited by the Ti:Sapphire laser pulsing between 840 and 900 nm according to experimental requirement, and collected by a 435/40-nm bandpass filter. For visualization of cell distribution in depth, stack images at 1-to 5-mm intervals were acquired via two-photon acquisition. Two-dimensional sections were processed by the reslice function of ImageJ.
Quantification of PRX1-Expressing Cells of the Coronal Sutures
Quantification of the PRX1-expressing cells was performed as previously described (Lo Celso et al., 2009 ) (n = 3-5 mice per time point).
Constitutive Lineage-Tracing Studies
Prx1-cre +/À male mice were crossed with tdTOMATO +/+ female mice. The Prx1Cre +/À ;tdTOMATO +/À male mice were analyzed by IVM at 8 weeks of age (n = 3 mice).
Constitutive Lineage-Ablation Studies
Prx1-cre +/À male mice were crossed with DTA +/+ female mice. P0
mice were collected immediately after birth, skinned, eviscerated, and fixed in 70% ethanol. An alizarin red/Alcian blue double-staining solution was used to distinguish calcified bone from cartilage for Prx1-cre
;DTA +/À test (n = 4 mice) and Prx1-cre
controls (n = 6 mice).
Constitutive Lineage-Tracing Studies during Bone Regeneration
Prx1-cre +/À male mice were crossed with tdTOMATO +/+ female mice to obtain Prx1-cre
;tdTOMATO +/À male mice. A 100-mm defect was created by femtosecond laser ablation in the left frontal calvaria and right posterior calvaria of 8-week-old male mice. IVM was used to visualize PRX1-lineage cells at 0, 5, 10, and 30 days after creation of the defect (n = 3 mice).
Inducible Lineage-Tracing Studies during Heterotopic Suture Transplantation
Four-week-old Prx1-creER-EGFP +/À ;tdTOMATO +/À male mice (donors) were euthanized to provide tissue transplants to 4-week-old wild-type male mice (recipients). Coronal and sagittal sutures were excised from the donors, chopped into fine chips, mixed with Matrigel, and stored on ice. Using a drill with a 1-mm round bur, a 2-mm defect was created carefully (so as not to damage the underlying dura) in the left and right parietal bones of the recipient mice. The right defect was filled with suture chips + Matrigel or with Matrigel only. Animals were treated with 100 mL of tamoxifen in sterile oil (test, n = 3 mice) or sterile oil only (control, n = 2 mice) for 2 days (40 mg/kg, intraperitoneally) following surgery and then euthanized on day 28. Calvaria were prepared for histological fluorescent analysis.
Inducible Lineage-Ablation Studies during Subcritical Defect Regeneration
Eight-week-old, male Prx1-creER-EGFP +/À ;DTA +/À mice (test, n = 6 mice) and Prx1-creER-EGFP À/À
;DTA +/À mice (control, n = 6 mice) were injected with tamoxifen (intraperitoneally, 40 mg/kg in sterile oil) for 5 days before and 5 days after surgery. A 0.5-mm defect was made in the right parietal bone using a 0.5-mm round bur. Twenty-eight days after surgery, calvarial samples were fixed in 70% EtOH for micro-computed tomography (mCT) analysis and histological processing.
Inducible Lineage-Tracing Studies during Bone Regeneration
Eight-week-old, male Prx1-creER-EGFP +/À ;tdTOMATO +/À mice were injected with tamoxifen (intraperitoneally, 40 mg/kg in sterile oil) for 3 days before making a 100-mm defect using femtosecond laser ablation. IVM was performed at the time of the defect creation (t0), 5 days after (t5), 10 days after (t10) (n = 6 mice), and 60 days after (t60) (n = 2 mice).
Suturectomy Studies
Eight-week-old, male Prx1-creER-EGFP +/À ;tdTOMATO +/ mice were used. Sutures were disrupted mechanically using a dental drill with a 0.25-mm diamond bur without perforating the dura. Bone defects (0.5 mm in diameter) were made 2 mm away from the sutures. Animals were euthanized 28 days after surgery and calvaria were dissected for histological processing (n = 5 mice/group).
Inducible Lineage-Tracing Studies during Orthotopic Suture Transplantation
Four-week-old, male Prx1-creER-EGFP +/À ;tdTOMATO +/À mice (donors) were euthanized to provide tissue to 4-week-old, male wildtype mice (recipients). The right coronal and sagittal sutures were excised from the donors and transplanted into an orthotopic site in recipient mice (after suturectomy). Six weeks after suture transplantation, a bone defect (0.5 mm in diameter) was made in the right parietal bone. Animals were injected with tamoxifen (intraperitoneally, 40 mg/kg in sterile oil) for 5 consecutive days to induce lineage tracing, and defects were imaged by IVM at days 7 and 14 postoperatively (n = 2 mice).
Single-Cell Clonogenicity Analysis
Four-week-old Prx1-creER-EGFP +/À mice were euthanized for EGFP + cell isolation from coronal and sagittal sutures using fluorescence-activated cell sorting (FACS 
WNT Stimulation Studies
For in vitro studies, EGFP + and EGFP À cells were sorted by FACS from calvaria of newborn animals (n = 5-7 animals) and seeded into 6-well plates in basic medium (aMEM, 20% FBS, 1% penicillin/streptomycin) for cell culture. Cells (passage 4) were treated with either 50 ng/mL of rmWNt3a or 1,000 ng/mL of rmDDK1 (R&D Systems) and incubated for 48 hr, or pretreated for 24 hr with 1,000 ng/mL of rmDKK1 (R&D Systems) and then stimulated with 50 ng/mL of rmWNT3a (R&D Systems) for 48 hr. qRT-PCR was performed using TaqMan real-time PCR assays (Life Technologies) (n = 3 independent experiments). For in vivo studies, 7-day-old Prx1-creER-EGFP +/À animals received calvarial subperiosteal injections of rmWnt3a (440 ng/day in PBS, R&D Systems) (n = 6 mice) or control (PBS) (n = 5 mice) for 2 consecutive days. After 24 hr, EGFP + cells were isolated from calvarial bones by FACS and qRT-PCR was performed using the Single Cell to CT kit (Thermo Fisher Scientific; cat. #4458237).
Inducible Lineage-Ablation Studies during Calvarial Development ;DTA +/À mice (control, n = 7 mice)
were injected with tamoxifen (intraperitoneally, 40 mg/kg in sterile oil) for 5 days and then aged for 2 months. Mice were euthanized and the cranium was removed for mCT analysis and histological processing. Calvarial measurements were taken using AVISO 3D software (FEI North America) following methodologies described elsewhere (Richtsmeier et al., 2000) . Long bone lengths were measured manually using a digital caliper. Methods were repeated for ablation of pnPRX1 + cells in 7-day-old animals (test n = 3, control n = 2).
Healing of Subcritical-Size Calvarial Defects after 2-Month Ablation of pnPRX1 + Cells ;DTA +/À male mice (control, n = 2) were injected with tamoxifen (intraperitoneally, 40 mg/kg in sterile oil) for 5 days. Sixty days later, a 0.5-mm defect was made in the right parietal bone using a 0.5-mm round bur. Twenty-eight days after surgery, calvarial samples were fixed in 70% EtOH for mCT analysis and histological processing.
Comparative Localization of pnPRX1 + Cells and (short-pulsing, n = 2). On day 6, animals were euthanized and their mandibles were dissected for fluorescent histological analysis.
Statistics
Statistical analysis was performed using two-tailed distribution equal-variance Student's t test, and results are shown as means ± SD. Statistically significant difference is indicated in figures as *p < 0.05 or **p < 0.01. 
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